特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

体外診断 (IVD) の世界市場の分析・予測

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology (Molecular Diagnostics, Clinical Chemistry), By Application, By End Use, And Segment Forecast, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 656140
出版日 ページ情報 英文 159 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.30円で換算しております。
体外診断 (IVD) の世界市場の分析・予測 In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology (Molecular Diagnostics, Clinical Chemistry), By Application, By End Use, And Segment Forecast, 2020 - 2027
出版日: 2020年02月11日 ページ情報: 英文 159 Pages
概要

当レポートでは、世界の体外診断 (IVD) の市場を調査し、市場の定義と概要、関連法規制、市場成長への各種影響因子の分析、提供内容・技術・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場の可変因子・動向・展望

  • 市場の展望
  • 普及・成長マッピング
  • 法規制上の枠組み
  • 市場力学
    • 成長推進因子の分析
    • 成長阻害因子の分析
  • 市場分析ツール
    • ポーターの分析
    • PESTEL分析
    • 主な提携・契約の分析

第4章 競合分析

  • 近年の展開・影響分析:主要参入事業者別
  • 企業の分類
  • ベンダー環境
  • 上場企業
  • 非上場企業

第5章 市場推計・動向分析:提供内容別

  • 定義・調査範囲
  • 市場シェア実績・予測
  • 市場予測・動向分析
    • 機器
    • 試薬
    • サービス

第6章 市場推計・動向分析:技術別

  • 定義・調査範囲
  • 市場シェア実績・予測
  • 市場予測・動向分析
    • 免疫測定
    • 血液学的検査
    • 臨床化学的検査 (生化学検査)
    • 分子診断
    • 凝固検査
    • 微生物検査
    • その他

第7章 市場推計・動向分析:用途別

  • 定義・調査範囲
  • 市場シェア実績・予測
  • 市場予測・動向分析
    • 感染症
    • 糖尿病
    • 心臓血管
    • 腎臓
    • 自己免疫疾患
    • 薬物検査
    • その他

第8章 市場推計・動向分析:エンドユーザー別

  • 定義・調査範囲
  • 市場シェア実績・予測
  • 市場予測・動向分析
    • 病院
    • ラボ
    • 在宅ケア
    • その他

第9章 市場推計・動向分析:地域・主要国別

  • 地域別動向
  • 主要企業
  • SWOT分析
  • 市場規模の推移・予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第10章 競合環境

  • 戦略的枠組み
  • ヒートマップ分析
  • Becton, Dickinson and Company
  • bioMerieux
  • Abbott Laboratories
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Danaher
  • Hologic, Inc. (Gen Probe)
  • Cepheid
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Instrumentation Laboratory
  • Leica Biosystems Nussloch Gmbh
  • Bio-Rad Laboratories, Inc.
  • Quidel Corporation
  • Qiagen N.V.
  • OraSure Technologies, Inc.
  • Stago
図表

List of Tables

  • TABLE 1 North America IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 2 North America IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 3 North America Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 4 North America Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 5 North America Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 6 North America Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 7 North America Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 8 North America Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 9 North America Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 10 North America IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 11 North America IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 12 U.S. IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 13 U.S. IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 14 U.S. Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 15 U.S. Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 16 U.S. Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 17 U.S. Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 18 U.S. Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 20 U.S. Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 22 U.S. IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 23 Canada IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 24 Canada IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 25 Canada Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 26 Canada Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 27 Canada Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 28 Canada Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 29 Canada Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 30 Canada Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 31 Canada Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 32 Canada IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 33 Canada IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 34 Europe IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 35 Europe IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 36 Europe Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 37 Europe Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 38 Europe Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 39 Europe Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 40 Europe Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 41 Europe Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 42 Europe Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 43 Europe IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 44 Europe IVD Market, by End-use2016 - 2027 (USD Million)
  • TABLE 45 U.K. IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 46 U.K. IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 47 U.K. Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 48 U.K. Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 49 U.K. Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 50 U.K. Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 51 U.K. Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 52 U.K. Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 53 U.K. Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 54 U.K. IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 55 U.K. IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 56 Germany IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 57 Germany IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 58 Germany Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 59 Germany Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 60 Germany Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 61 Germany Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 62 Germany Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 63 Germany Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 64 Germany Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 65 Germany IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 66 Germany IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 67 Spain IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 68 Spain IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 69 Spain Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 70 Spain Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 71 Spain Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 72 Spain Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 73 Spain Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 74 Spain Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 75 Spain Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 76 Spain IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 77 Spain IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 78 France IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 79 France IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 80 France Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 81 France Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 82 France Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 83 France Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 84 France Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 85 France Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 86 France Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 87 France IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 88 France IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 89 Italy IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 90 Italy IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 91 Italy Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 92 Italy Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 93 Italy Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 94 Italy Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 95 Italy Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 96 Italy Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 97 Italy Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 98 Italy IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 99 Italy IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 100 Russia IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 101 Russia IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 102 Russia Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 103 Russia Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 104 Russia Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 105 Russia Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 106 Russia Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 107 Russia Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 108 Russia Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 109 Russia IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 110 Russia IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 111 Asia Pacific IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 112 Asia Pacific IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 113 Asia Pacific Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 114 Asia Pacific Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 115 Asia Pacific Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 116 Asia Pacific Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 117 Asia Pacific Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 118 Asia Pacific Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 119 Asia Pacific Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 120 Asia Pacific IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 121 Asia Pacific IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 122 Japan IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 123 Japan IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 124 Japan Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 125 Japan Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 126 Japan Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 127 Japan Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 128 Japan Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 129 Japan Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 130 Japan Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 131 Japan IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 132 Japan IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 133 China IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 134 China IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 135 China Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 136 China Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 137 China Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 138 China Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 139 China Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 140 China Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 141 China Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 142 China IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 143 China IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 144 India IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 145 India IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 146 India Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 147 India Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 148 India Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 149 India Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 150 India Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 151 India Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 152 India Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 153 India IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 154 India IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 155 South Korea IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 156 South Korea IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 157 South Korea Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 158 South Korea Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 159 South Korea Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 160 South Korea Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 161 South Korea Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 162 South Korea Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 163 South Korea Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 164 South Korea IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 165 South Korea IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 166 Singapore IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 167 Singapore IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 168 Singapore Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 169 Singapore Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 170 Singapore Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 171 Singapore Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 172 Singapore Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 173 Singapore Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 174 Singapore Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 175 Singapore IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 176 Singapore IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 177 Australia IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 178 Australia IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 179 Australia Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 180 Australia Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 181 Australia Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 182 Australia Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 183 Australia Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 184 Australia Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 185 Australia Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 186 Australia IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 187 Australia IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 188 Latin America IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 189 Latin America IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 190 Latin America Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 191 Latin America Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 192 Latin America Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 193 Latin America Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 194 Latin America Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 195 Latin America Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 196 Latin America Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 197 Latin America IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 198 Latin America IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 199 Brazil IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 200 Brazil IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 201 Brazil Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 202 Brazil Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 203 Brazil Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 204 Brazil Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 205 Brazil Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 206 Brazil Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 207 Brazil Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 208 Brazil IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 209 Brazil IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 210 Mexico IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 211 Mexico IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 212 Mexico Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 213 Mexico Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 214 Mexico Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 215 Mexico Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 216 Mexico Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 217 Mexico Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 218 Mexico Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 219 Mexico IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 220 Mexico IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 221 Argentina IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 222 Argentina IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 223 Argentina Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 224 Argentina Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 225 Argentina Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 226 Argentina Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 227 Argentina Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 228 Argentina Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 229 Argentina Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 230 Argentina IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 231 Argentina IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 232 MEA IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 233 MEA IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 234 MEA Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 235 MEA Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 236 MEA Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 237 MEA Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 238 MEA Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 239 MEA Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 240 MEA Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 241 MEA IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 242 MEA IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 243 South Africa IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 244 South Africa IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 245 South Africa Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 246 South Africa Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 247 South Africa Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 248 South Africa Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 249 South Africa Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 250 South Africa Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 251 South Africa Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 252 South Africa IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 253 South Africa IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 254 UAE IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 255 UAE IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 256 UAE Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 257 UAE Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 258 UAE Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 259 UAE Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 260 UAE Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 261 UAE Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 262 UAE Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 263 UAE IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 264 UAE IVD Market, by End-use, 2016 - 2027 (USD Million)
  • TABLE 265 Saudi Arabia IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 266 Saudi Arabia IVD Market, by Technique, 2016 - 2027 (USD Million)
  • TABLE 267 Saudi Arabia Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 268 Saudi Arabia Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 269 Saudi Arabia Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 270 Saudi Arabia Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 271 Saudi Arabia Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 272 Saudi Arabia Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 273 Saudi Arabia Others IVD Market, by Product, 2016 - 2027 (USD Million)
  • TABLE 274 Saudi Arabia IVD Market, by Application, 2016 - 2027 (USD Million)
  • TABLE 275 Saudi Arabia IVD Market, by End-use, 2016 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global IVD - Key market driver analysis
  • FIG. 7 Global IVD market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global IVD market - Porter's analysis
  • FIG. 10 Global IVD market - PESTEL analysis
  • FIG. 11 Global IVD market product outlook key takeaways
  • FIG. 12 Global IVD market: Product movement analysis
  • FIG. 13 Instruments market estimates, 2016 - 2027 (USD Million)
  • FIG. 14 Reagents market estimates, 2016 - 2027 (USD Million)
  • FIG. 15 Services market estimates, 2016 - 2027 (USD Million)
  • FIG. 16 Global IVD market technology outlook key takeaways
  • FIG. 17 Global IVD market: Technology movement analysis
  • FIG. 18 Immunology market estimates, 2016 - 2027 (USD Million)
  • FIG. 19 Hematology market estimates, 2016 - 2027 (USD Million)
  • FIG. 20 Clinical Chemistry market estimates, 2016 - 2027 (USD Million)
  • FIG. 21 Molecular Diagnostics market estimates, 2016 - 2027 (USD Million)
  • FIG. 22 Coagulation market estimates, 2016 - 2027 (USD Million)
  • FIG. 23 Microbiology market estimates, 2016 - 2027 (USD Million)
  • FIG. 24 Others market estimates, 2016 - 2027 (USD Million)
  • FIG. 25 Global IVD market application outlook key takeaways
  • FIG. 26 Global IVD market: Application movement analysis
  • FIG. 27 Infectious Diseases market estimates, 2016 - 2027 (USD Million)
  • FIG. 28 Diabetes market estimates, 2016 - 2027 (USD Million)
  • FIG. 29 Oncology market estimates, 2016 - 2027 (USD Million)
  • FIG. 30 Cardiology market estimates, 2016 - 2027 (USD Million)
  • FIG. 31 Nephrology market estimates, 2016 - 2027 (USD Million)
  • FIG. 32 Autoimmune Diseases market estimates, 2016 - 2027 (USD Million)
  • FIG. 33 Drug Testing market estimates, 2016 - 2027 (USD Million)
  • FIG. 34 Others market estimates, 2016 - 2027 (USD Million)
  • FIG. 35 Global IVD market end-use outlook key takeaways
  • FIG. 36 Global IVD market: End-use movement analysis
  • FIG. 37 Hospitals market estimates, 2016 - 2027 (USD Million)
  • FIG. 38 Laboratory market estimates, 2016 - 2027 (USD Million)
  • FIG. 39 Home Care market estimates, 2016 - 2027 (USD Million)
  • FIG. 40 Other market estimates, 2016 - 2027 (USD Million)
  • FIG. 41 Regional market place: Key takeaways
  • FIG. 42 Global IVD market: Regional movement analysis
  • FIG. 43 North America IVD market, 2016 - 2027 (USD Million)
  • FIG. 44 U.S. IVD Market, 2016 - 2027 (USD Million)
  • FIG. 45 Canada IVD Market, 2016 - 2027 (USD Million)
  • FIG. 46 Europe IVD market, 2016 - 2027 (USD Million)
  • FIG. 48 U.K. IVD market, 2016 - 2027 (USD Million)
  • FIG. 49 Germany IVD market, 2016 - 2027 (USD Million)
  • FIG. 50 Spain IVD market, 2016 - 2027 (USD Million)
  • FIG. 51 France IVD market, 2016 - 2027 (USD Million)
  • FIG. 52 Italy IVD market, 2016 - 2027 (USD Million)
  • FIG. 53 Russia IVD market, 2016 - 2027 (USD Million)
  • FIG. 54 Asia Pacific IVD market, 2016 - 2027 (USD Million)
  • FIG. 55 Japan IVD market, 2016 - 2027 (USD Million)
  • FIG. 56 China IVD market, 2016 - 2027 (USD Million)
  • FIG. 57 India IVD market, 2016 - 2027 (USD Million)
  • FIG. 58 South Korea IVD market, 2016 - 2027 (USD Million)
  • FIG. 59 Singapore IVD market, 2016 - 2027 (USD Million)
  • FIG. 60 Australia IVD market, 2016 - 2027 (USD Million)
  • FIG. 61 Latin America IVD market, 2016 - 2027 (USD Million)
  • FIG. 62 Brazil IVD market, 2016 - 2027 (USD Million)
  • FIG. 63 Mexico IVD market, 2016 - 2027 (USD Million)
  • FIG. 64 Argentina IVD market, 2016 - 2027 (USD Million)
  • FIG. 65 MEA IVD market, 2016 - 2027 (USD Million)
  • FIG. 66 South Africa IVD market, 2016 - 2027 (USD Million)
  • FIG. 67 UAE market, 2016 - 2027 (USD Million)
  • FIG. 68 Saudi Arabia IVD market, 2016 - 2027 (USD Million)
  • FIG. 69 Strategy framework
  • FIG. 70 Heat map analysis
  • FIG. 71 Becton, Dickinson and Company overview
  • FIG. 72 bioMerieux overview
  • FIG. 73 Abbott Laboratories, Inc. overview
  • FIG. 74 Sysmex Corporation overview
  • FIG. 75 Ortho Clinical Diagnostics overview
  • FIG. 76 Danaher overview
  • FIG. 77 Hologic, Inc. overview
  • FIG. 78 Cepheid overview
  • FIG. 79 F. Hoffmann-La Roche Ltd overview
  • FIG. 80 Siemens Healthineers overview
  • FIG. 81 Stago overview
  • FIG. 82 Instrumentation Laboratory overview
  • FIG. 83 Leica Biosystems Nussloch Gmbh overview
目次
Product Code: 978-1-68038-080-4

The global in vitro diagnostics (IVD) market is expected to reach USD 85.8 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to exhibit a 4.4% CAGR over the forecast period. Development of simplified diagnostic tests is expected to drive the growth. For instance, Cepheid's Xpert HCV VL Fingerstick received CE-IVD clearance in September 2018. This test identifies and measures HCV RNA levels from fingerstick blood sample.

Key players are developing new products and undertaking strategic initiatives, such as collaborations, mergers and acquisitions to gain greater market share and to expand their product portfolio. For instance, in February 2018, a product named PAXgene Blood ccfDNA tube was made available by BD for non-invasive prenatal testing and cancer diagnosis and application in the European Economic Area (EEA) and Switzerland. PAXgene Blood ccfDNA tube was developed by Qiagen-PreAnalytiX GmbH and BD in a joint venture.

Rising geriatric population and favorable government regulations to spur the approval process of medical devices are the factors expected to drive the market over the forecast period. For instance, in August 2018, approval process for IVD was eased in an amended provision in the Fourth Schedule of Medical Devices Rule by the central government of India.

Furthermore, increasing demand for early diagnosis to strategize complete treatment plans for patients by the physicians is projected to fuel the demand for user-friendly in vitro diagnostic products. For instance, in July 2017, bioMerieux for VITEK MS received the U.S. Food and Drug Administration (FDA) approval. It is a mass spectrometry system that rapidly identifies pathogens, such as Nocardia mycobacteria, and molds.

Reagents held the largest market share in 2019, owing to development of analytical laboratory automation coupled with high usage rate of reagents. For instance, in July 2018, Surmodics, Inc. launched MatrixGuard Diluent that blocks matrix or assay signal and maintains intended signals.

Increasing prevalence cancer, cardiovascular disorders, diabetes, and other diseases is expected to accelerate the demand for in vitro diagnostics in the forthcoming years. According to Cancer Research UK, in 2018, about 17 million new cancer cases were reported across the world. It has estimated that the incidence rate of the disease will witness a 62% rise from 2018 to 2040. Liver, stomach, breast, lung, and colorectal are the most common types of cancer.

Further key findings from the report suggest:

  • Molecular diagnostics segment is expected to witness the fastest growth over the forecast period, owing to the high usage of the technology for disease diagnosis
  • Infectious disease application segment dominated the market in 2019 due to rising prevalence of tuberculosis, hepatitis, and other infectious diseases
  • North America dominated the in vitro diagnostics market in 2019, owing to presence of key players and a rise in launch of new products in major countries like U.S. and Canada
  • Asia Pacific is expected to exhibit the fastest CAGR over the forecast period owing to number of products are being launched in hospitals to provide accurate diagnosis
  • Major IVD market players are Qiagen; Danaher; Becton, Dickinson and Company; Siemens Healthineers; F. Hoffmann-La Roche Ltd.; Hologic, Inc. (Gen-Probe); bioMerieux SA; Abbott Laboratories; Cepheid; and Sysmex Corporation

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Market segmentation & scope
  • 1.3. Market definition
  • 1.4. Information procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources & third party perspectives
    • 1.4.4. Primary research
  • 1.5. Information analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & data visualization
  • 1.7. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global IVD Market Variables, Trends & Scope

  • 3.1. IVD Market Lineage outlook
    • 3.1.1. Medical Technology market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Regulatory Framework
    • 3.3.1. Reimbursement framework
    • 3.3.2. Standards & Compliances
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing demand for point of care diagnostics
      • 3.4.1.2. Growing geriatric population
      • 3.4.1.3. Introduction of technologically advanced diagnostics
      • 3.4.1.4. Increasing prevalence of chronic diseases
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. High cost of devices
      • 3.4.2.2 Stringent regulatory policies
  • 3.5. Global IVD Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power: (Moderate to high due to presence of many manufacturers)
      • 3.5.1.2. Buyer Power: (Low due to presence of primary clinics and diagnostic labs entering into long-term contract)
      • 3.5.1.3. Substitution Threat: (Moderate to Low due to high Accuracy of diagnostic results)
      • 3.5.1.4. Threat from new entrant: (Moderate due to brand recognition of the existing players)
      • 3.5.1.5. Competitive rivalry: (High due to increasing mergers & acquisitions by major players)
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
      • 3.5.3.1. Joint Ventures
      • 3.5.3.2. Mergers & Acquisitions
      • 3.5.3.3. Licensing & Partnership
      • 3.5.3.4. Technology Collaborations
      • 3.5.3.5. Strategic Divestments

Chapter 4. Global IVD Market - Competitive Analysis

  • 4.1. Recent developments & impact analysis, by key market participants
  • 4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.3. Vendor Landscape
    • 4.3.1. List of key distributors and channel partners
    • 4.3.2. Key company market share analysis, 2019
  • 4.4. Public Companies
    • 4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.4.2. Company Market Share
    • 4.4.3. Competitive Dashboard Analysis
    • 4.4.4. Market Differentiators
    • 4.4.5. Synergy Analysis: Major Deals & Strategic Alliances
  • 4.5. Private Companies
    • 4.5.1. List of key emerging companies
    • 4.5.2. Regional network map
    • 4.5.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)

Chapter 5. Global IVD Market: Product Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Global IVD Market, by Product, 2016 - 2027
  • 5.3. Market Size & Forecasts and Trend Analyses, 2016 - 2027 for the following,
    • 5.3.1. Instruments
      • 5.3.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
    • 5.3.2. Reagents
      • 5.3.1.1 Reagents IVD Market, 2016 - 2027 (USD Million)
    • 5.3.3. Services
      • 5.3.1.1 Services IVD Market, 2016 - 2027 (USD Million)

Chapter 6. Global IVD Market: Technology Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Technology market share analysis, 2019 & 2027
  • 6.3. Global IVD Market, by Technology, 2016 to 2027
  • 6.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 6.4.1. Immunoassay
      • 6.4.1.1 Immunoassay IVD Market, 2016 - 2027 (USD Million)
    • 6.4.2. Hematology
      • 6.4.2.1 Hematology IVD Market, 2016 - 2027 (USD Million)
    • 6.4.3. Clinical Chemistry
      • 6.4.3.1 Clinical Chemistry IVD Market, 2016 - 2027 (USD Million)
    • 6.4.4. Molecular Diagnostics
      • 6.4.4.1 Molecular Diagnostics IVD Market, 2016 - 2027 (USD Million)
    • 6.4.5. Coagulation
      • 6.4.5.1 Coagulation IVD Market, 2016 - 2027 (USD Million)
    • 6.4.6. Microbiology
      • 6.4.6.1 Microbiology IVD Market, 2016 - 2027 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1 Others IVD Market, 2016 - 2027 (USD Million)
  • 6.5. Technology Markets, by Product, 2016 to 2027:
    • 6.5.1. Immunoassay
      • 6.5.1.1 Instruments
      • 6.5.1.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
      • 6.5.2.1 Reagents
      • 6.5.2.1.1 Reagents IVD Market, 2016 - 2027 (USD Million)
      • 6.5.3.1 Services
      • 6.5.3.1.1 Services IVD Market, 2016 - 2027 (USD Million)
    • 6.5.2. Hematology
      • 6.5.2.1 Instruments
      • 6.5.2.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
      • 6.5.2.2. Reagents
      • 6.5.2.2.1 Reagents IVD Market, 2016 - 2027 (USD Million)
      • 6.5.2.3 Services
      • 6.5.2.3.1 Services IVD Market, 2016 - 2027 (USD Million)
    • 6.5.3. Clinical Chemistry
      • 6.5.3.1 Instruments
      • 6.5.3.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
      • 6.5.3.2. Reagents
      • 6.5.3.2.1 Reagents IVD Market, 2016 - 2027 (USD Million)
      • 6.5.3.3 Services
      • 6.5.3.3.1 Services IVD Market, 2016 - 2027 (USD Million)
    • 6.5.4. Molecular Diagnostics
      • 6.5.4.1 Instruments
      • 6.5.4.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
      • 6.5.4.2. Reagents
      • 6.5.4.2.1 Reagents IVD Market, 2016 - 2027 (USD Million)
      • 6.5.4.3 Services
      • 6.5.4.3.1 Services IVD Market, 2016 - 2027 (USD Million)
    • 6.5.5. Coagulation
      • 6.5.5.1 Instruments
      • 6.5.5.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
      • 6.5.5.2. Reagents
      • 6.5.5.2.1 Reagents IVD Market, 2016 - 2027 (USD Million)
      • 6.5.5.3 Services
      • 6.5.5.3.1 Services IVD Market, 2016 - 2027 (USD Million)
    • 6.5.6. Microbiology
      • 6.5.6.1 Instruments
      • 6.5.6.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
      • 6.5.6.2. Reagents
      • 6.5.6.2.1 Reagents IVD Market, 2016 - 2027 (USD Million)
      • 6.5.6.3 Services
      • 6.5.6.3.1 Services IVD Market, 2016 - 2027 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1 Instruments
      • 6.5.7.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
      • 6.5.7.2. Reagents
      • 6.5.7.2.1 Reagents IVD Market, 2016 - 2027 (USD Million)
      • 6.5.7.3 Services
      • 6.5.7.3.1 Services IVD Market, 2016 - 2027 (USD Million)

Chapter 7. Global IVD Market: Application Estimates & Trend Analysis

  • 7.1. Definitions & Scope
  • 7.2. Application market share analysis, 2019 & 2027
  • 7.3. Global IVD Market, by Application, 2016 to 2027
  • 7.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 7.4.1. Infectious Disease
      • 7.4.1.1 Infectious Disease IVD Market, 2016 - 2027 (USD Million)
    • 7.4.2. Diabetes
      • 7.4.2.1 Diabetes IVD Market, 2016 - 2027 (USD Million)
    • 7.4.3. Oncology
      • 7.4.3.1 Oncology IVD Market, 2016 - 2027 (USD Million)
    • 7.4.4. Cardiology
      • 7.4.4.1 Cardiology IVD Market, 2016 - 2027 (USD Million)
    • 7.4.5. Nephrology
      • 7.4.5.1 Nephrology IVD Market, 2016 - 2027 (USD Million)
    • 7.4.6. Autoimmune Disease
      • 7.4.6.1 Autoimmune Disease IVD Market, 2016 - 2027 (USD Million)
    • 7.4.7. Drug Testing
      • 7.4.7.1 Drug Testing IVD Market, 2016 - 2027 (USD Million)
    • 7.4.8. Others
      • 7.4.8.1 Others IVD Market, 2016 - 2027 (USD Million)

Chapter 8. Global IVD Market: End Use Estimates & Trend Analysis

  • 8.1. Definitions & Scope
  • 8.2. End Use market share analysis, 2019 & 2027
  • 8.3. Global IVD Market, by End Use, 2016 to 2027
  • 8.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 8.4.1. Hospitals
      • 8.4.1.1 Instrument IVD Market, 2016 - 2027 (USD Million)
    • 8.4.2. Laboratories
      • 8.4.2.1 Instrument IVD Market, 2016 - 2027 (USD Million)
    • 8.4.3. Home Care
      • 8.4.3.1 Instrument IVD Market, 2016 - 2027 (USD Million)
    • 8.4.4. Others
      • 8.4.4.1 Instrument IVD Market, 2016 - 2027 (USD Million)

Chapter 9 Global IVD Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, & End-use

  • 9.1 Global IVD Market: Regional Movement Analysis, 2019 & 2027
  • 9.2 Global IVD Market: Leading Players, 2019:
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa
  • 9.4 North America
    • 9.4.1 North America IVD market, 2016 - 2027 (USD Million)
    • 9.4.2 U.S.
      • 9.4.2.1 U.S. IVD Market, 2016 - 2027 (USD Million)
    • 9.4.3 Canada
      • 9.4.3.1 Canada IVD Market, 2016 - 2027 (USD Million)
  • 9.5. Europe
    • 9.5.1 Europe IVD market, 2016 - 2027 (USD Million)
    • 9.5.3 U.K.
      • 9.5.3.1 U.K. IVD market, 2016 - 2027 (USD Million)
    • 9.5.2 Germany
      • 9.5.2.1 Germany IVD market, 2016 - 2027 (USD Million)
    • 9.5.3 Spain
      • 9.5.3.1 Spain IVD market, 2016 - 2027 (USD Million)
    • 9.5.3 France
      • 9.5.3.1 France IVD market, 2016 - 2027 (USD Million)
    • 9.5.3 Italy
      • 9.5.3.1 Italy IVD market, 2016 - 2027 (USD Million)
    • 9.5.3 Russia
      • 9.5.3.1 Russia IVD market, 2016 - 2027 (USD Million)
  • 9.6 Asia Pacific
    • 9.6.1 Asia Pacific IVD market, 2016 - 2027 (USD Million)
    • 9.6.2 Japan
      • 9.6.2.1 Japan IVD market, 2016 - 2027 (USD Million)
    • 9.6.3 India
      • 9.6.3.1 India IVD market, 2016 - 2027 (USD Million)
    • 9.6.4 South Korea
      • 9.6.4.1 South Korea IVD market, 2016 - 2027 (USD Million)
    • 9.6.5 Singapore
      • 9.6.5.1 Singapore IVD market, 2016 - 2027 (USD Million)
    • 9.6.6 Australia
      • 9.6.6.1 Australia IVD market, 2016 - 2027 (USD Million)
  • 9.7 Latin America
    • 9.7.1 Latin America IVD market, 2016 - 2027 (USD Million)
    • 9.7.2 Brazil
      • 9.7.2.1 Brazil IVD market, 2016 - 2027 (USD Million)
    • 9.7.3 Mexico
      • 9.7.3.1 Mexico IVD market, 2016 - 2027 (USD Million)
    • 9.7.4 Argentina
      • 9.7.4.1 Argentina IVD market, 2016 - 2027 (USD Million)
  • 9.8 MEA
    • 9.8.1 MEA IVD market, 2016 - 2027 (USD Million)
    • 9.8.2 South Africa
      • 9.8.2.1 South Africa IVD market, 2016 - 2027 (USD Million)
    • 9.8.3 United Arab Emirates
      • 9.8.3.1 United Arab Emirates IVD market, 2016 - 2027 (USD Million)
    • 9.8.4 Saudi Arabia
      • 9.8.4.1 Saudi Arabia IVD market, 2016 - 2027 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Strategy Framework
  • 10.2 Heat Map Analysis of Private Companies
    • 10.2.1 Company size
    • 10.2.2 Distribution network
    • 10.2.3 Product portfolio
    • 10.2.4 Segment coverage
    • 10.2.5 Geographic presence
    • 10.2.6 Collaborations
    • 10.2.7 Conclusion
  • 10.3 Becton, Dickinson and Company
    • 10.3.1 Company overview
    • 10.3.2 Financial performance
    • 10.3.3 Product benchmarking
    • 10.3.4 Strategic initiatives
  • 10.4 bioMerieux
    • 10.4.1 Company overview
    • 10.4.2 Financial performance
    • 10.4.3 Product benchmarking
    • 10.4.4 Strategic initiatives
  • 10.5 Abbott Laboratories
    • 10.5.1 Company overview
    • 10.5.2 Financial performance
    • 10.5.3 Product benchmarking
    • 10.5.4 Strategic initiatives
  • 10.6 Sysmex Corporation
    • 10.6.1 Company overview
    • 10.6.2 Financial performance
    • 10.6.3 Product benchmarking
    • 10.6.4 Strategic initiatives
  • 10.7 Ortho Clinical Diagnostics
    • 10.7.1 Company overview
    • 10.7.2 Financial performance
    • 10.7.3 Product benchmarking
    • 10.7.4 Strategic initiatives
  • 10.8 Danaher
    • 10.8.1 Company overview
    • 10.8.2 Financial performance
    • 10.8.3 Product benchmarking
    • 10.8.4 Strategic initiatives
  • 10.9 Hologic, Inc. (Gen Probe)
    • 10.9.1 Company overview
    • 10.9.2 Financial performance
    • 10.9.3 Product benchmarking
    • 10.9.4 Strategic initiatives
  • 10.10 Cepheid
    • 10.10.1 Company overview
    • 10.10.2 Product benchmarking
    • 10.10.3 Strategic initiatives
  • 10.11 F. Hoffmann-La Roche Ltd
    • 10.11.1 Company Overview
    • 10.11.2 Financial performance
    • 10.11.3 Product benchmarking
    • 10.11.4 Strategic initiatives
  • 10.12 Siemens Healthineers
    • 10.12.1 Company overview
    • 10.12.2 Financial performance
    • 10.12.3 Product benchmarking
    • 10.12.4 Strategic initiatives
  • 10.13 Instrumentation Laboratory
    • 10.13.1 Company overview
    • 10.13.2 Financial overview
    • 10.13.3 Product benchmarking
    • 10.13.4 Strategic initiatives
  • 10.14 Leica Biosystems Nussloch Gmbh
    • 10.14.1 Company overview
    • 10.14.2 Product benchmarking
    • 10.14.3 Strategic initiatives
  • 10.15 Bio-Rad Laboratories, Inc.
    • 10.15.1 Company overview
    • 10.15.2 Financial performance
    • 10.15.3 Product benchmarking
    • 10.15.4 Strategic initiatives
  • 10.16 Quidel Corporation
    • 10.16.1 Company overview
    • 10.16.2 Financial performance
    • 10.16.3 Products benchmarking
    • 10.16.4 Strategic initiatives
  • 10.17 Qiagen N.V.
    • 10.17.1 Company overview
    • 10.17.2 Financial performance
    • 10.17.3 Product benchmarking
    • 10.17.4 Strategic initiatives
  • 10.18 OraSure Technologies, Inc.
    • 10.18.1 Company overview
    • 10.18.2 Financial performance
    • 10.18.3 Products benchmarking
    • 10.18.4 Strategic initiatives
  • 10.19 Stago
    • 10.19.1 Company overview
    • 10.19.2 Product benchmarking
    • 10.19.3 Strategic initiatives